Skip to main content

Table 1 Distribution of demographics for patients with oligometastatic EGAC

From: Perioperative FLOT chemotherapy plus surgery for oligometastatic esophagogastric adenocarcinoma: surgical outcome and overall survival

  Gastric carcinoma (n = 31) Esophageal carcinoma (n = 17) Total (n = 48)
Sex
 Female 11 (35%) 4 (23%) 15 (31%)
 Male 20 (64%) 13 (76%) 33 (69%)
 Age in years* 55.1 (33.6–81.1) 58.3 (30.2–80) 56.8 (30.2–81.2)
ASA classification
 ASA 1–2 17 (55%) 12 (70%) 29 (60%)
 ASA 3–4 14 (45%) 5 (29%) 19 (39%)
 BMI in kg/m2* 26.3 (18.0–41.7) 24.5 (20.5–38.1) 25.3 (18.0–41.7)